Edition:
United Kingdom

Juno Therapeutics Inc (JUNO.OQ)

JUNO.OQ on NASDAQ Stock Exchange Global Select Market

44.76USD
4:10pm GMT
Change (% chg)

$-2.65 (-5.59%)
Prev Close
$47.41
Open
$47.60
Day's High
$48.62
Day's Low
$44.51
Volume
335,502
Avg. Vol
729,882
52-wk High
$63.33
52-wk Low
$17.52

Select another date:

Wed, Dec 6 2017

BRIEF-Juno Therapeutics Signs Licensing Agreements With Lilly, Oncotracker, And Fred Hutchinson Cancer Research Center

* JUNO THERAPEUTICS SIGNS LICENSING AGREEMENTS WITH LILLY, ONCOTRACKER, AND FRED HUTCHINSON CANCER RESEARCH CENTER TO ADVANCE ITS BCMA-DIRECTED ENGINEERED T CELL PROGRAM IN MULTIPLE MYELOMA WITH GAMMA SECRETASE INHIBITION

BRIEF-Juno Therapeutics reports Q3 adjusted loss per share ‍$0.73​

* Juno Therapeutics reports third quarter 2017 financial results

BRIEF-Juno Therapeutics and Trianni sign licensing agreement for use of Trianni Transgenic Mouse platform

* Trianni and Juno Therapeutics sign licensing agreement for use of Trianni Transgenic Mouse platform

BRIEF-Juno Therapeutics prices $250 million follow-on offering

* Juno Therapeutics- Announced pricing of its follow-on public offering of 6.1 million shares of its common stock at a price to public of $41.00 per share Source text for Eikon: Further company coverage:

BRIEF-Juno Therapeutics files for offering of common stock aggregate offering price of $225 mln - SEC Filing‍​

* Juno Therapeutics Inc - Files for offering of common stock; aggregate offering price of $225 million - SEC Filing‍​ Source text for Eikon: Further company coverage:

BRIEF-Juno Therapeutics qtrly ‍loss per share $0.96

* Juno Therapeutics reports second quarter 2017 financial results

Select another date: